Author

Omid Mohammad Tavakoli‐Rouzbehani

University of UtahORCID 0000-0003-0880-9229Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Andrew Paul LandstromiD· 1 shared Ava Leonelli· 1 shared Benjamin WerbneriD· 1 shared Crystal F. Davey· 1 shared Marta W. SzulikiD· 1 shared Martin G. GolkowskiiD· 1 shared Michael Goodman· 1 shared Mira Hua· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPhysiology

Andrew Paul LandstromORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

PhysiologybioRxivPreprintApr 15, 2026

Perm1 Gene Therapy Mitigates PRDM16-Associated Cardiomyopathy

Omid Mohammad Tavakoli‐Rouzbehani, Sophie L. Stephens, Benjamin Werbner…·Sihem Boudina

This study identifies PERM1 as a downstream target of PRDM16 and shows that Perm1 gene therapy improves cardiomyopathy in Prdm16 knockout mice through mitochondrial and sarcomere preservation.

DOI 10.64898/2026.04.13.718330

mouseproteomics

𝕏 PostBluesky